These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 9153539)

  • 1. Past use of oral contraceptives and the risk of developing systemic lupus erythematosus.
    Sanchez-Guerrero J; Karlson EW; Liang MH; Hunter DJ; Speizer FE; Colditz GA
    Arthritis Rheum; 1997 May; 40(5):804-8. PubMed ID: 9153539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral contraceptive use and mortality during 12 years of follow-up: the Nurses' Health Study.
    Colditz GA
    Ann Intern Med; 1994 May; 120(10):821-6. PubMed ID: 8154642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contraceptive practice in women with systemic lupus erythematosus.
    Julkunen HA; Kaaja R; Friman C
    Br J Rheumatol; 1993 Mar; 32(3):227-30. PubMed ID: 8448613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus.
    Sánchez-Guerrero J; Liang MH; Karlson EW; Hunter DJ; Colditz GA
    Ann Intern Med; 1995 Mar; 122(6):430-3. PubMed ID: 7856991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimates of the risk of cardiovascular death attributable to low-dose oral contraceptives in the United States.
    Schwingl PJ; Ory HW; Visness CM
    Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):241-9. PubMed ID: 9914611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46 000 women from Royal College of General Practitioners' oral contraception study.
    Beral V; Hermon C; Kay C; Hannaford P; Darby S; Reeves G
    BMJ; 1999 Jan; 318(7176):96-100. PubMed ID: 9880284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study of pregravid oral contraceptive use and risk of hypertensive disorders of pregnancy.
    Thadhani R; Stampfer MJ; Chasan-Taber L; Willett WC; Curhan GC
    Contraception; 1999 Sep; 60(3):145-50. PubMed ID: 10640157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hair dye use and the risk of developing systemic lupus erythematosus.
    Sánchez-Guerrero J; Karlson EW; Colditz GA; Hunter DJ; Speizer FE; Liang MH
    Arthritis Rheum; 1996 Apr; 39(4):657-62. PubMed ID: 8630117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors.
    McTiernan AM; Weiss NS; Daling JR
    Am J Epidemiol; 1984 Sep; 120(3):423-35. PubMed ID: 6475918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer among young U.S. women in relation to oral contraceptive use.
    White E; Malone KE; Weiss NS; Daling JR
    J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of low-dose oral contraceptives and stroke in young women.
    Schwartz SM; Siscovick DS; Longstreth WT; Psaty BM; Beverly RK; Raghunathan TE; Lin D; Koepsell TD
    Ann Intern Med; 1997 Oct; 127(8 Pt 1):596-603. PubMed ID: 9341057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification of Systemic Lupus Erythematosus: Systemic Lupus International Collaborating Clinics Versus American College of Rheumatology Criteria. A Comparative Study of 2,055 Patients From a Real-Life, International Systemic Lupus Erythematosus Cohort.
    Inês L; Silva C; Galindo M; López-Longo FJ; Terroso G; Romão VC; Rúa-Figueroa I; Santos MJ; Pego-Reigosa JM; Nero P; Cerqueira M; Duarte C; Miranda LC; Bernardes M; Gonçalves MJ; Mouriño-Rodriguez C; Araújo F; Raposo A; Barcelos A; Couto M; Abreu P; Otón-Sanchez T; Macieira C; Ramos F; Branco JC; Silva JA; Canhão H; Calvo-Alén J; ;
    Arthritis Care Res (Hoboken); 2015 Aug; 67(8):1180-5. PubMed ID: 25581417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of serious illness among oral contraceptive users: evidence from the RCGP's oral contraceptive study.
    Hannaford PC; Kay CR
    Br J Gen Pract; 1998 Oct; 48(435):1657-62. PubMed ID: 10071398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study of exogenous hormones and risk of pulmonary embolism in women.
    Grodstein F; Stampfer MJ; Goldhaber SZ; Manson JE; Colditz GA; Speizer FE; Willett WC; Hennekens CH
    Lancet; 1996 Oct; 348(9033):983-7. PubMed ID: 8855854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata.
    Marshall LM; Spiegelman D; Goldman MB; Manson JE; Colditz GA; Barbieri RL; Stampfer MJ; Hunter DJ
    Fertil Steril; 1998 Sep; 70(3):432-9. PubMed ID: 9757871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant hypertension and antiphospholipid antibodies as presenting features of SLE in a young woman using oral contraceptives.
    Julkunen H; Kaaja R; Jouhikainen T; Teppo AM; Friman C
    Br J Rheumatol; 1991 Dec; 30(6):471-2. PubMed ID: 1747706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives.
    Chie WC; Li CY; Huang CS; Chang KJ; Yen ML; Lin RS
    Int J Cancer; 1998 Jul; 77(2):219-23. PubMed ID: 9650556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptives and breast cancer in young women.
    Stadel BV; Rubin GL; Webster LA; Schlesselman JJ; Wingo PA
    Lancet; 1985 Nov; 2(8462):970-3. PubMed ID: 2865503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
    Jick H; Jick SS; Gurewich V; Myers MW; Vasilakis C
    Lancet; 1995 Dec; 346(8990):1589-93. PubMed ID: 7500750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.